PA
| |
PERCEPTIVE ADVISORS LLC13F | |
PERCEPTIVE ADVISORS LLC | |
Last update 2024-10-29 | 110 Stocks (19 new) |
Value $4.15 Bil | Turnover 9 % |
Portfolio Report |
PERCEPTIVE ADVISORS LLC Top Holdings of 2024-06-30
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CERE | Cerevel Therapeutics Holdings Inc | 10,794,876 | 441402.480 | 0% | 10.630 | 0% | 5.930 | +5.47% | +6.04% | 8191.475 | Biotechnology | |
FOLD | Amicus Therapeutics Inc | 28,057,456 | 278329.960 | 0% | 6.700 | 0% | 9.460 | +22.93% | -17.27% | 3481.979 | Biotechnology | |
ACLX | Arcellx Inc | 3,889,739 | 214674.700 | -1.11% | 5.170 | -0.05% | 7.240 | +70.52% | +56.97% | 4683.198 | Biotechnology | |
IOVA | Iovance Biotherapeutics Inc | 25,933,142 | 207983.800 | +34.56% | 5.010 | +1.29% | 8.540 | +57.14% | +43.42% | 3538.971 | Biotechnology | |
NUVL | Nuvalent Inc | 2,549,077 | 193372.980 | -8.42% | 4.660 | -0.31% | 3.930 | +28.12% | +24.89% | 6484.030 | Biotechnology | |
RYTM | Rhythm Pharmaceuticals Inc | 3,446,579 | 141516.530 | +5.45% | 3.410 | +0.18% | 5.640 | +27.69% | +22.30% | 3438.778 | Biotechnology | |
PCVX | Vaxcyte Inc | 1,862,608 | 140645.530 | -3.63% | 3.390 | -0.08% | 1.670 | +47.87% | +71.27% | 13314.088 | Biotechnology | |
SLNO | Soleno Therapeutics Inc | 3,204,976 | 130763.020 | +4.24% | 3.150 | +0.13% | 8.250 | +24.51% | +40.10% | 2191.971 | Biotechnology | |
ITCI | Intra-Cellular Therapies Inc | 1,716,407 | 117556.720 | +62.64% | 2.830 | +1.09% | 1.620 | +14.70% | +24.60% | 9460.969 | Drug Manufacturers | |
IMTX | Immatics NV | 8,086,159 | 93961.170 | +76.46% | 2.260 | +0.98% | 7.840 | -17.53% | -11.11% | 1117.173 | Biotechnology |
PERCEPTIVE ADVISORS LLC's Historical Top Holdings Breakdowns
PERCEPTIVE ADVISORS LLC's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
FUSN | Fusion Pharmaceuticals Inc | 2024-06-30 | Sold Out | -2.55% | 21.24 ($21.41) 21.55 | $21.55 | 0.65% | Sold Out | 0 | -6,825,395 | |
INBX | Inhibrx Inc | 2024-06-30 | Sold Out | -2.38% | 30.54 ($30.93) 31.5 | $15.70 | -49.24% | Sold Out | 0 | -4,256,104 | |
MDT | Medtronic PLC | 2024-06-30 | Reduce | -1.43% | 78.71 ($81.98) 87.02 | $89.68 | 9.39% | Reduce -65.68% | 490,665 | -938,898 | |
IOVA | Iovance Biotherapeutics Inc | 2024-06-30 | Add | +1.29% | 7.78 ($10.72) 14.19 | $11.66 | 8.77% | Add 34.56% | 25,933,142 | 6,660,151 | |
SRPT | Sarepta Therapeutics Inc | 2024-06-30 | Sold Out | -1.19% | 113.33 ($128.46) 163.85 | $125.01 | -2.69% | Sold Out | 0 | -525,683 | |
ITCI | Intra-Cellular Therapies Inc | 2024-06-30 | Add | +1.09% | 64.76 ($69.36) 79.84 | $89.24 | 28.66% | Add 62.64% | 1,716,407 | 661,052 | |
IMTX | Immatics NV | 2024-06-30 | Add | +0.98% | 9.78 ($11.27) 13.49 | $9.36 | -16.95% | Add 76.46% | 8,086,159 | 3,503,750 | |
AXSM | Axsome Therapeutics Inc | 2024-06-30 | Reduce | -0.90% | 65.72 ($74.04) 80.5 | $89.24 | 20.53% | Reduce -58.46% | 459,111 | -646,230 | |
MDGL | Madrigal Pharmaceuticals Inc | 2024-06-30 | Reduce | -0.77% | 193.33 ($238.04) 291.99 | $337.61 | 41.83% | Reduce -38.46% | 264,600 | -165,353 | |
CTNM | Contineum Therapeutics Inc | 2024-06-30 | New Buy | +0.66% | 14.09 ($16.1) 20.8 | $16.60 | 3.11% | New holding | 1,566,668 | 1,566,668 |
PERCEPTIVE ADVISORS LLC Total Holding History ($B)
PERCEPTIVE ADVISORS LLC's Asset Allocation
PERCEPTIVE ADVISORS LLC Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
PERCEPTIVE ADVISORS LLC's Hypothetical Growth since 2024-06-30
PERCEPTIVE ADVISORS LLC's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
PERCEPTIVE ADVISORS LLC's Holdings Heat Map
Size field:
PERCEPTIVE ADVISORS LLC's Holdings Bubble Chart
PERCEPTIVE ADVISORS LLC News
- 1